Margin Index Is Not a Reliable Tool for Predicting Residual Disease after Breast-Conserving Surgery for DCIS
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Surgery
Link
http://link.springer.com/content/pdf/10.1245/s10434-011-1918-6.pdf
Reference26 articles.
1. Poller DN. Pathology of ductal carcinoma in situ of the breast: current status. Eur J Surg Oncol. 2001;27:498–503.
2. Boyages J, Delaney G, Taylor R. Predictors of local recurrence after treatment of ductal carcinoma in-situ: a meta-analysis. Cancer. 1999;77:2189–92.
3. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–41.
4. Fisher ER, Dignam J, Fisher E, Tan-Chiu C, Fisher C. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of protocol B-17. Cancer. 1999;86:429–38.
5. Silverstein MJ, Lagios MD. Choosing treatment for patients with ductal carcinoma in situ: fine tuning the University of Southern California/Van Nuys prognostic index. J Natl Cancer Inst Monogr. 2010;41:193–6.
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Prognostic factors for residual occult disease in shave margins during partial mastectomy;Breast Cancer Research and Treatment;2021-06-16
2. Risk factors for the presence of residual disease in women after partial mastectomy for invasive breast cancer: A single institution experience;Surgical Oncology;2021-06
3. Surgical management of ductal carcinoma in situ of the breast: A large retrospective study from a single institution;The Breast Journal;2019-07-18
4. Current controversies in the treatment of ductal carcinoma in situ of the breast;Translational Cancer Research;2018-04
5. Re-excision rates after breast conserving surgery following the 2014 SSO-ASTRO guidelines;The American Journal of Surgery;2017-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3